235 related articles for article (PubMed ID: 19800226)
1. Small molecule inhibitors of Myc/Max dimerization and Myc-induced cell transformation.
Shi J; Stover JS; Whitby LR; Vogt PK; Boger DL
Bioorg Med Chem Lett; 2009 Nov; 19(21):6038-41. PubMed ID: 19800226
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts.
Berg T; Cohen SB; Desharnais J; Sonderegger C; Maslyar DJ; Goldberg J; Boger DL; Vogt PK
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3830-5. PubMed ID: 11891322
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
[TBL] [Abstract][Full Text] [Related]
4. Stopping MYC in its tracks.
Stefan E; Hart JR; Bister K
Aging (Albany NY); 2015 Jul; 7(7):463-4. PubMed ID: 26187009
[No Abstract] [Full Text] [Related]
5. In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-Myc/Max dimerization.
Clausen DM; Guo J; Parise RA; Beumer JH; Egorin MJ; Lazo JS; Prochownik EV; Eiseman JL
J Pharmacol Exp Ther; 2010 Dec; 335(3):715-27. PubMed ID: 20801893
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization.
Lu X; Vogt PK; Boger DL; Lunec J
Oncol Rep; 2008 Mar; 19(3):825-30. PubMed ID: 18288422
[TBL] [Abstract][Full Text] [Related]
7. Structural aspects of interactions within the Myc/Max/Mad network.
Nair SK; Burley SK
Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule modulators of c-Myc/Max and Max/Max interactions.
Berg T
Curr Top Microbiol Immunol; 2011; 348():139-49. PubMed ID: 20680803
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of protein-protein interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization.
Banerjee A; Hu J; Goss DJ
Biochemistry; 2006 Feb; 45(7):2333-8. PubMed ID: 16475822
[TBL] [Abstract][Full Text] [Related]
10. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
Gupta K; Anand G; Yin X; Grove L; Prochownik EV
Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
[TBL] [Abstract][Full Text] [Related]
11. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
[TBL] [Abstract][Full Text] [Related]
12. In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential.
Raffeiner P; Röck R; Schraffl A; Hartl M; Hart JR; Janda KD; Vogt PK; Stefan E; Bister K
Oncotarget; 2014 Oct; 5(19):8869-78. PubMed ID: 25326649
[TBL] [Abstract][Full Text] [Related]
13. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
[TBL] [Abstract][Full Text] [Related]
14. A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation.
Castell A; Yan Q; Fawkner K; Hydbring P; Zhang F; Verschut V; Franco M; Zakaria SM; Bazzar W; Goodwin J; Zinzalla G; Larsson LG
Sci Rep; 2018 Jul; 8(1):10064. PubMed ID: 29968736
[TBL] [Abstract][Full Text] [Related]
15. Small Molecule MYC Inhibitor Conjugated to Integrin-Targeted Nanoparticles Extends Survival in a Mouse Model of Disseminated Multiple Myeloma.
Soodgupta D; Pan D; Cui G; Senpan A; Yang X; Lu L; Weilbaecher KN; Prochownik EV; Lanza GM; Tomasson MH
Mol Cancer Ther; 2015 Jun; 14(6):1286-1294. PubMed ID: 25824336
[TBL] [Abstract][Full Text] [Related]
16. Stabilizers of the Max homodimer identified in virtual ligand screening inhibit Myc function.
Jiang H; Bower KE; Beuscher AE; Zhou B; Bobkov AA; Olson AJ; Vogt PK
Mol Pharmacol; 2009 Sep; 76(3):491-502. PubMed ID: 19498040
[TBL] [Abstract][Full Text] [Related]
17. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
Wahlström T; Belikov S; Arsenian Henriksson M
Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
[TBL] [Abstract][Full Text] [Related]
18. Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells.
Grinberg AV; Hu CD; Kerppola TK
Mol Cell Biol; 2004 May; 24(10):4294-308. PubMed ID: 15121849
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight inhibitors of Myc-Max interaction and function.
Yin X; Giap C; Lazo JS; Prochownik EV
Oncogene; 2003 Sep; 22(40):6151-9. PubMed ID: 13679853
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]